questionText: To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential impact of shortages of pancreatic enzyme replacement therapy medications on patients.
answerText: The Department is continuing to engage with all suppliers of pancreatic enzyme replacement therapy (PERT) to boost production to mitigate the supply issue. Through this work we have managed to secure additional volumes of PERT for 2025. The Department has...
heading: Pancreatic Enzyme Replacement Therapy: Drugs